Cart
sales@molnova.com
Enpp-1-IN-16
CAS No. 2289739-47-3
Enpp-1-IN-16( —— )
Catalog No. M37145 CAS No. 2289739-47-3
Enpp-1-IN-16 is an inhibitor targeting ENPP1 with potential anti-cancer activity.Enpp-1-IN-16 can be used to study insulin resistance in relation to type II diabetes mellitus and various ENPP1-mediated diseases in the chondrocalcinosis and osteoarthritis classes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 76 | Get Quote |
|
| 10MG | 122 | Get Quote |
|
| 25MG | 266 | Get Quote |
|
| 50MG | 419 | Get Quote |
|
| 100MG | 647 | Get Quote |
|
| 500MG | 1341 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameEnpp-1-IN-16
-
NoteResearch use only, not for human use.
-
Brief DescriptionEnpp-1-IN-16 is an inhibitor targeting ENPP1 with potential anti-cancer activity.Enpp-1-IN-16 can be used to study insulin resistance in relation to type II diabetes mellitus and various ENPP1-mediated diseases in the chondrocalcinosis and osteoarthritis classes.
-
DescriptionEnpp-1-IN-16 (compound 54) is an ENPP1 inhibitor. Enpp-1-IN-16 has the potential to study cancer, especially in cases of high ENPP1 expression or elevated cytoplasmic DNA levels. Enpp-1-IN-16 can also be used in other diseases mediated by ENPP1, such as bacterial or viral infections, insulin resistance and type II diabetes, chondrocalcinosis and osteoarthritis, calcium pyrophosphate deposition disorder (CPPD), low Phosphatase disease and soft tissue calcification disorders.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2289739-47-3
-
Formula Weight428.52
-
Molecular FormulaC23H32N4O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 2 mg/mL (4.67 mM; Ultrasonic )
-
SMILESO=C(OC(C)(C)C)N1CCC2(C1)CCN(C=3N=CN=C4C=C(OC)C(OC)=CC43)CC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Derek A Cogan, et al. Imino sulfanone inhibitors of enpp1. WO2021225969A1.
molnova catalog
related products
-
BI 1015550
Nerandomilast (BI 1015550) is an orally active PDE4B inhibitor with IC50 of 7.2 nM. BI 1015550 has potential applications in inflammation, allergic diseases, pulmonary fibrosis and chronic obstructive pulmonary disease (COPD) with a good safety profile.
-
Carbazeran
Carbazeran is an inhibitor of PDE2 and PDE3 and can be used for studies about metabolic diseases. Carbazeran shows inotropic and chronotropic effects in vivo(EC50 = 100 μM).
-
Dovramilast
Dovramilast (CC-11050) is an orally active phosphodiesterase 4 (PDE4) inhibitor that reduces the production of pro-inflammatory mediators and cytokines.
